WINDLAS
Windlas Biotech Limited
Pharmaceuticals · ₹1,747 Cr market cap
A leading pharmaceutical contract development and manufacturing organization, Windlas Biotech specializes in producing solid and liquid dosage forms for domestic and international clients. The company provides comprehensive CDMO services including product discovery, development, and commercial manufacturing of generic and complex generic medications. Its vertically integrated operations, technical capabilities, and focus on quality manufacturing distinguish it within India's pharmaceutical sector.
1
Tracked investors holding
1
Tracked moves
₹826
Share price
Latest activity
ICICI Prudential Mutual FundDecreased
ICICI Prudential Mutual Fund sold 5,40,642 shares of Windlas Biotech for ₹43.12 crore at ₹797.55 apiece, decreasing its stake from 6.96% to 4.33% and crossing the 5% disclosure threshold.
Top investors holding Windlas Biotech Limited
5.19%
Track smart money in Windlas Biotech Limited
Get alerted when a top investor buys or sells.
Get started